Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive Care

Inclusion Criteria: * Patient admitted to the CIC unit for a first episode of acute coronary syndrome, in whom the CIC cardiologist considers that Crestor® -rosuvastatin is the most appropriate statin, in combination with a platelet aggregation inhibitor (Plavix®-clopidogrel) * Patient giving his/her oral consent to participate in the study. * Patient not previously treated by a lipid-lowering drug. Exclusion Criteria: * Patient with a known history of coronary heart disease. * Patient whose treatment on discharge comprises only one of the two study treatments * Patient participating or who has participated in the previous 3 months in a biomedical research study in cardiology.